BindingDB logo
myBDB logout
Solution Informationhelp
Enzyme: Lysosomal acid glucosylceramidase
inhibitor: BDBM42394
substrate: n/a
 
Solution Type: Aqueous
pH at Preparation: n/a
Temp. Prep.: n/a
Comments: Assay Overview: The purpose of this assay is to determine dose response curves for test compounds identified as active in a previous screen entitled, "Primary Cell-based high throughput screening assay for enhancers of beta-glucosidase activity," (PubChem AID 784). In this assay, activation of beta-glucosidase was measured using fibroblasts cells derived from a Gaucher disease patient with the homozygous L444P beta-glucosidase mutation. These cells have significantly reduced lysosomal glucosidase activity as a result of misfolding and degradation of the mutant protein, which reduces the amount of enzyme in the lysosome. Cells are treated with test compounds for 3 days to allow the enzyme to accumulate in the lysosome, followed by treatment with the fluorescent beta-glucosidase substrate 4-Methylumbelliferyl-B-D-glucopyranoside (MUD). As designed, a compound that acts as a beta-glucosidase activator will increase cleavage of MUD, and as a result increase well fluorescence. Compou
 
 

If you find an error in this entry please send us an E-mail
   
    

Home

|

Search

|

Deposit

|

SiteMap

|

About us

|

Email us

|

Info

 
Last update November 1, 2007
©2000 BindingDB. All rights reserved.